Mostrar registro simples

dc.contributor.authorPereira, Ivânio Alvespt_BR
dc.contributor.authorPileggi, Gecilmara Cristina Salviatopt_BR
dc.contributor.authorMota, Licia Maria Henrique dapt_BR
dc.contributor.authorFronza, Lucila Stange Rezendept_BR
dc.contributor.authorCruz, Boris Afonsopt_BR
dc.contributor.authorBrenol, Claiton Viegaspt_BR
dc.contributor.authorBertolo, Manoel Barrospt_BR
dc.contributor.authorFreitas, Max Victor Carioca dept_BR
dc.contributor.authorSilva, Nilzio Antonio dapt_BR
dc.contributor.authorLouzada Junior, Paulopt_BR
dc.contributor.authorGiorgi, Rina Dalva Neubarthpt_BR
dc.contributor.authorLima, Rodrigo Aires Corrêapt_BR
dc.contributor.authorPinheiro, Geraldo da Rocha Castelarpt_BR
dc.date.accessioned2016-08-10T02:15:57Zpt_BR
dc.date.issued2013pt_BR
dc.identifier.issn0482-5004pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/147012pt_BR
dc.description.abstractObjective: To elaborate recommendations to the vaccination of patients with rheumatoid arthritis (RA) in Brazil. Method: Literature review and opinion of expert members of the Brazilian Society of Rheumatology Committee of Rheumatoid Arthritis and of an invited pediatric rheumatologist. Results and conclusions: The following 12 recommendations were established: 1) Before starting disease-modifying anti-rheumatic drugs, the vaccine card should be reviewed and updated; 2) Vaccines against seasonal infl uenza and against H1N1 are indicated annually for patients with RA; 3) The pneumococcal vaccine should be indicated for all patients with RA; 4) The vaccine against varicella should be indicated for patients with RA and a negative or dubious history for that disease; 5) The HPV vaccine should be considered for adolescent and young females with RA; 6) The meningococcal vaccine is indicated for patients with RA only in the presence of asplenia or complement defi ciency; 7) Asplenic adults with RA should be immunized against Haemophilus infl uenzae type B; 8) An additional BCG vaccine is not indicated for patients diagnosed with RA; 9) Hepatitis B vaccine is indicated for patients with RA who are negative for antibodies against HBsAg; the combined hepatitis A and B vaccine should be considered; 10) Patients with RA and at high risk for tetanus, who received rituximab in the preceding 24 weeks, should undergo passive immunization with tetanus immunoglobulin in case of exposure; 11) The YF vaccine is contraindicated to patients with RA on immunosuppressive drugs; 12) The above described recommendations should be reviewed over the course of RA.en
dc.format.mimetypeapplication/pdf
dc.language.isoengpt_BR
dc.relation.ispartofRevista brasileira de reumatologia. Campinas. Vol. 53, n. 1 (jan./fev. 2013), p. 4-23pt_BR
dc.rightsOpen Accessen
dc.subjectRheumatoid arthritisen
dc.subjectArtrite reumatóidept_BR
dc.subjectConsensopt_BR
dc.subjectVaccinationen
dc.subjectImmunizationen
dc.subjectVacinaçãopt_BR
dc.subjectAdulten
dc.title2012 Brazilian Society of Rheumatology Consensus on vaccination of patients with rheumatoid arthritispt_BR
dc.title.alternativeConsenso 2012 da Sociedade Brasileira de Reumatologia sobre vacinação em pacientes com artrite reumatoide pt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000986383pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples